Clinical Trials Browser

INDUSTRY × irinotecan sucrosofate × Other solid neoplasm × Clear all

NCT03810742 2023-11-18

Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors

NCT05086822 2021-10-21

A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT02884128 2016-08-30

A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor